Lexeo Therapeutics (LXEO) Treasury Shares (2024 - 2026)
Lexeo Therapeutics recorded quarterly Treasury Shares of $382933.0 in Q1 2026, down 45.57% quarter-over-quarter from $703578.0 in Q4 2025.
Lexeo Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- In Q1 2026, Treasury Shares changed N/A year-over-year to $382933.0; the TTM figure through Mar 2026 stood at $382933.0 (changed N/A YoY), while the FY2025 annual figure was $703578.0, up 164.21% from the prior year.
- Treasury Shares came in at $382933.0 for Q1 2026 at Lexeo Therapeutics, down from $703578.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $17000.0 in Q4 2024 to a low of $13000.0 in Q2 2024.
- A 3-year average of $16000.0 and a median of $17000.0 in 2024 frame the typical range for Treasury Shares.
- On a YoY basis, Treasury Shares climbed as much as 174.76% in 2025 and fell as far as 27.95% in 2025.
- Lexeo Therapeutics' Treasury Shares stood at $266300.0 in 2024, then surged by 164.21% to $703578.0 in 2025, then sank by 45.57% to $382933.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $17000.0, $17000.0, and $17000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | 382,933.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382,933.00 |
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 382,933.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 703,578.00 |
| Dec 31, 2025 | 703,578.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 3,827.00 |
| Sep 30, 2025 | 3,827.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 738,291.00 |
| Jun 30, 2025 | 738,291.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 266,300.00 |
| Dec 31, 2024 | 266,300.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 2,991.00 |
| Sep 30, 2024 | 2,991.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 268,700.00 |
| Jun 30, 2024 | 268,700.00 |
| Mar 31, 2024 | 224,945.00 |
| Mar 31, 2024 | 224,945.00 |